Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus sporogenes and Improved Hepatic Function

Doses used in studies

CFU/day: 1 billion (median 1 billion, IQR 1 billion–1 billion) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant differenceno significant differences between groups
mammographic density, endometrial thickness and hepatic function did not show significant differences between groups
from: Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in p

1 of 1 paper

Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women.
- 2012-11-30
- RCT · n = 65
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 29(3)
- - Nicola Colacurci
  - Pasquale De Franciscis
  - Marco Atlante
  - Pasquale Mancino
  - Marco Monti
  - Giuseppe Volpini
  - Claudio Benvenuti
- PubMed: 23194023
- DOI: 10.3109/09513590.2012.738724
4 Insights on
- Improved Hepatic Function
- High evidence
- Clinical
After 12 months of treatment mammographic density, endometrial thickness and hepatic function did not show significant differences between groups
Effect
Neutral
Effect size
Small
Significant
No
Dose
1 billion spores